Full Text View
Tabular View
No Study Results Posted
Related Studies
GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1
This study has been terminated.
( Unable to recruit adaquate number of GHB dependent subjects )
Study NCT00123578   Information provided by National Institute on Drug Abuse (NIDA)
First Received: July 22, 2005   Last Updated: November 19, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sodium Oxybate
Substance-Related Disorders
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Interventions listed in this trial
Lorazepam
Pentobarbital
More general drug interventions related to this trial
Adjuvants, Anesthesia
Anti-Anxiety Agents
Anticonvulsants
Antiemetics
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Modulators
Gastrointestinal Agents
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services